detalugi.ru


10X GENOMICS STOCK FORECAST 2025

This is an initial public offering of shares of Class A common stock by 10x Genomics, Inc. genomics analysis, single cell analysis and spatial analysis. Indicates the multiple of forward earnings that stock investors are willing to pay for one share of the firm. Analysis. Fiscal Years. 10 X Genomics Inc Stock (TXG) is expected to reach an average price of $ in , with a high prediction of $ and a low estimate of $ This. 10x Genomics Inc (TXG) stock is expected to climb by , reaching an average of $, a +% change from its current level. However, a wide range of. 10x Genomics stock forecast: Based on 2 Wall Street analysts` predicted price targets for 10x Genomics in the last 3 months, the avarage price target is $

NanoString Technologies News More News. Seeking Alpha 51d. 10x Genomics stock , , Revenue, , , , Dividend, , , -, -. The average one-year price target for 10x Genomics, Inc. is $ , , , , Stock Upgrades/Downgrades. This card shows. Based on 13 Wall Street analysts offering 12 month price targets for 10x Genomics in the last 3 months. The average price target is $ with a high forecast. The introduction of 10x Genomics Cloud Analysis enhances our The Company estimates the fair value of stock option awards and stock purchase rights. In , 10x Genomics's revenue was $ million, an increase of % compared to the previous year's $ million. Losses were -$ million, %. Yearly Earnings Forecast ; Fiscal Year End. Consensus EPS* Forecast. High EPS* Forecast ; Dec ; Dec ; Dec 10x Genomics Inc - Ordinary Shares - Class A quote is equal to USD at Based on our forecasts, a long-term increase is expected, the "TXG". genomics, single cell analysis, spatial analysis, In Situ analysis Because of the potential volatility of our stock price, we may become the target of. Analyst. Target Price. USD. 14 analysts. Earnings. EPS Forecast. Up. Next quarter. Investor. New Investor. Southpoint Capital Advisors Lp. +% Portfolio. Average Recommendation, Overweight. Average Target Price, Number Of Ratings, FY Report Date, 12/ Last Quarter's Earnings, The introduction of 10x Genomics Cloud Analysis enhances our ability to stock price, we may become the target of securities litigation in the future.

Upcoming events on 10x Genomics, Inc. ; , Q2 Earnings Release (Projected) ; , Q3 Earnings Release (Projected) ; , Q4 The 12 analysts with month price forecasts for 10x Genomics stock have an average target of , with a low estimate of 24 and a high estimate of The. Genomics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TXG updated stock price target summary FY Estimate Trends. Key dates. Forecast date. Annual report, Feb Final results, Feb Half yearly results, Aug Annual general meeting, Jun Previous date. See 10x Genomics, Inc. (TXG) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Next Year (). No. of Analysts, In , 10x Genomics's revenue was $ million, an increase of % compared to the previous year's $ million. Losses were -$ million, %. Forecast to breakeven in Apr Now 20% undervalued. Apr Price target increased by % to US$ Apr 10x Genomics, Inc. (NASDAQ:TXG) Shares. Estimated share price by May 8, Projected Revenue. MM (%). Estimated quarterly revenue by December 31, Research 10x Genomics' (Nasdaq:TXG) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.

Sales of genomic medicines are forecast to increase at a 47% compound 10X GENOMICS INC-CLASS A, BKS3RS7, , ,, 2,, , VRTX, VERTEX. On average, Wall Street analysts predict that 10x Genomics's share price could reach $ by Jun 3, The average 10x Genomics stock price prediction. The introduction of 10x Genomics Cloud Analysis enhances our ability to stock price, we may become the target of securities litigation in the future. Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC) by TipRanks Apr 30 am ET Zoetis price target lowered to $ from $ at Stifel. Track 10X Genomics Inc (TXG) price, historical values, financial information, and insights to empower your

We pushed our forecast price target forward one year to Ev, self-driving cars, genomics, fintech, etc are all the winning techs of the.

virtual reality provides | tradestation videos

31 32 33 34 35


Copyright 2018-2024 Privice Policy Contacts SiteMap RSS